Documents|Accelerate screening during drug discovery with high-throughput peptide purification
Accelerate screening during drug discovery with high-throughput peptide purification
The absence of impurities in peptides, synthesized via SPPS, is vital for reliable assay results. However, especially in drug discovery screenings (number of peptides > 24), potentially low-purity crude peptides are often used because parallel purification with chromatography is not possible. We overcome this bottleneck by parallelization of the orthogonal PurePep® EasyClean (PEC) purification technology to a 96 well-plate format.
Download Options
DownloadE-mail a CopyAccelerate screening during drug discovery with high-throughput peptide purification